Contact Us

News

  • DSIR Approved R&D Centre

    R&D and ADL centre has certified by DSIR, Govt. of India.

    2020-10-16 08:52:49

  • WHO - GMP

    OSD Plant at Thane has been renewed with WHO GMP Certificate by CDSCO by Government of India

    2025-09-01 08:10:04

  • Eurasian GMP

    OSD plant at Thane has been approved by Eurasian authority for EAEU GMP for Tablet, Capsule, Liquid Oral and Ointment & Cream Facility

    2025-09-01 08:12:56

Quote

  • Company has Successfully started the opration at its Goa Plant for Oncology Products 

  • Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg  And  Favipiravir 200 mg/400mg/800mg Tablet.

RND & ADL ATGAON THANE
  • Lok-Beta has independent Research & Development facility approved by DSIR, Government of India. 
  • Development new formulation in different segment of niche molecules equipped with well qualified personnel supported by latest technology and machine. Spread over separate 650 Sq. M. block.
  •  R&D and ADL has bright future and lot of new latest non patented molecules are under development and the same will be commercialized in a upcoming six months.
  • Lok-Beta niche molecules such as Antiretroviral, Immunosuppressant, Urological, Antihypertensive, Anti diabetics and Anti Tuberculosis are aim is to provide /develop new formulation and application for the human well-being.
  • Lok-Beta developed more than 40 Niche molecules and rigorously planning for develop @10 new core products yearly